Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 23, Number 6—June 2017

Clinical and Molecular Characteristics of Human Rotavirus G8P[8] Outbreak Strain, Japan, 2014

Kenji Kondo, Takeshi TsugawaComments to Author , Mayumi Ono, Toshio Ohara, Shinsuke Fujibayashi, Yasuo Tahara, Noriaki Kubo, Shuji Nakata, Yoshihito Higashidate, Yoshiki Fujii, Hirokazu Kimura, Yuko Yoto, and Hiroyuki Tsutsumi
Author affiliations: Sapporo Medical University School of Medicine, Sapporo, Japan (K. Kondo, T. Tsugawa, M. Ono, Y. Yoto, H. Tsutsumi); Tomakomai City Hospital, Tomakomai, Japan (T. Ohara); Tomakomai Children's Clinic, Tomakomai (S. Fujibayashi); Steel Memorial Muroran Hospital, Muroran, Japan (Y. Tahara); Japanese Red Cross Urakawa Hospital, Urakawa, Japan (N. Kubo); Nakata Pediatric Clinic, Sapporo (S. Nakata); Sapporo Hokushin Hospital, Sapporo (Y. Higashidate); National Institute of Infectious Diseases, Tokyo, Japan (Y. Fujii, K. Katayama)

Main Article

Table 1

Characteristics of patients infected with (G8P[8] and non-G8P[8] rotavirus, Tomakomai, Hokkaido Prefecture, Japan, 2014

Patient characteristic Patients infected with rotavirus
p value*
G8P[8], n = 42 Non-G8P[8], n = 42
Sex, no. 1.0
M 24 24

Median age, y
Vaccinated, no (%)
2 (4.8)
1 (2.4)
Clinical symptoms, mean ± SD
Duration of fever, d 1.3 ± 1.2 1.7 ± 1.4 0.13
Duration of diarrhea, d 2.4 ± 1.6 2.5 ± 3.2 0.51
Diarrhea episode in 24 h, maximum no. 3.6 ± 3.2 4.3 ± 4.2 0.69
Duration of vomiting, d 1.4 ± 1.2 1.8 ± 2.9 0.79
Vomiting episodes in 24 h, maximum no. 3.6 ± 3.8 3.7 ± 3.5 0.98
Admitted to hospital, no. (%) 18 (42.9%) 16 (38.1%) 0.66

*Categorical data were analyzed by using χ2 tests; continuous data were analyzed by using Student’s t-tests or Mann-Whitney U tests.

Main Article

Page created: May 16, 2017
Page updated: May 16, 2017
Page reviewed: May 16, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.